Keenova Therapeutics plc Intangible Assets, Net (Excluding Goodwill)
Keenova Therapeutics plc had Intangible Assets, Net (Excluding Goodwill) of $1.72 billion as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2026-08-11
- 2026-06-30: Intangible Assets, Net (Excluding Goodwill) $1.72B.
- 2026-03-31: Intangible Assets, Net (Excluding Goodwill) $2.17B.
- 2025-12-31: Intangible Assets, Net (Excluding Goodwill) $2.23B.
- 2025-09-26: Intangible Assets, Net (Excluding Goodwill) $2.56B.
| Period end | Intangible Assets, Net (Excluding Goodwill) | Intangible Assets, Net (Excluding Goodwill) as first filed |
|---|---|---|
| 2026-06-30 | $1.72B 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $2.17B 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $2.23B 10-Q · filed 2026-08-11 | |
| 2025-09-26 | $2.56B 10-Q · filed 2025-11-10 | |
| 2025-06-27 | $393.10M 10-Q · filed 2025-08-06 | |
| 2025-03-28 | $406.10M 10-Q · filed 2025-05-12 | |
| 2024-12-27 | $171.70M 10-K · filed 2026-04-15 | $419.40M 10-K · filed 2025-03-13 |
| 2024-09-27 | $433.70M 10-Q · filed 2024-11-05 | |
| 2024-06-28 | $560.30M 10-Q · filed 2024-08-06 | |
| 2024-03-29 | $583.70M 10-Q · filed 2024-05-09 | |
| 2023-12-29 | $608.40M 10-K · filed 2025-03-13 | |
| 2023-11-14 | $361.10M 10-K · filed 2026-04-15 | |
| 2023-09-29 | $2.32B 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $2.58B 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $2.71B 10-Q · filed 2023-05-09 | |
| 2022-12-30 | $2.84B 10-K · filed 2024-03-26 | |
| 2022-09-30 | $2.98B 10-Q · filed 2022-11-08 | |
| 2022-07-01 | $3.11B 10-Q · filed 2022-08-11 | |
| 2022-04-01 | $5.29B 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $5.45B 10-K · filed 2023-03-03 | |
| 2021-09-24 | $5.68B 10-Q · filed 2021-11-02 | |
| 2021-06-25 | $5.83B 10-Q · filed 2021-08-03 | |
| 2021-03-26 | $5.97B 10-Q · filed 2021-05-04 | |
| 2020-12-25 | $6.18B 10-K · filed 2022-03-15 | |
| 2020-09-25 | $6.36B 10-Q · filed 2020-11-03 | |
| 2020-06-26 | $6.57B 10-Q · filed 2020-08-04 | |
| 2020-03-27 | $6.82B 10-Q · filed 2020-05-06 | |
| 2019-12-27 | $7.02B 10-K · filed 2021-03-10 | |
| 2019-09-27 | $7.50B 10-Q · filed 2019-11-05 | |
| 2019-06-28 | $7.72B 10-Q · filed 2019-08-06 | |
| 2019-03-29 | $8.06B 10-Q · filed 2019-05-07 | |
| 2018-12-28 | $8.28B 10-K · filed 2020-02-26 | |
| 2018-09-28 | $8.59B 10-Q · filed 2018-11-06 | |
| 2018-06-29 | $8.77B 10-Q · filed 2018-08-07 | |
| 2018-03-30 | $8.95B 10-Q · filed 2018-05-08 | |
| 2017-12-29 | $8.38B 10-K · filed 2019-02-26 | |
| 2017-09-29 | $8.55B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $8.60B 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $8.78B 10-Q · filed 2017-05-08 | |
| 2016-12-30 | $9.00B 10-K · filed 2018-02-27 | |
| 2016-09-30 | $9.18B 10-QT · filed 2017-02-07 | |
| 2016-06-24 | $9.26B 10-Q · filed 2016-08-02 | |
| 2016-03-25 | $9.43B 10-Q · filed 2016-05-03 | |
| 2015-12-25 | $9.49B 10-Q · filed 2016-02-02 | |
| 2015-09-25 | $9.67B 10-K · filed 2016-11-29 | |
| 2015-06-26 | $8.68B 10-Q · filed 2015-08-04 | |
| 2015-03-27 | $6.86B 10-Q · filed 2015-05-05 | |
| 2014-12-26 | $6.98B 10-Q · filed 2015-02-03 | |
| 2014-09-26 | $7.08B 10-K · filed 2015-11-24 | $7.11B 10-K · filed 2014-11-25 |
| 2014-06-27 | $1.66B 10-Q · filed 2014-08-07 | |
| 2014-03-28 | $1.72B 10-Q · filed 2014-05-08 | |
| 2013-12-27 | $413.30M 10-Q · filed 2014-02-07 | |
| 2013-09-27 | $422.10M 8-K · filed 2015-04-03 | |
| 2013-06-28 | $430.90M 10-Q · filed 2013-08-12 | |
| 2012-09-28 | $365.60M 10-K · filed 2013-12-13 |